3.Joint statement to consolidate the pharmacovigilance systems for securing safety of the COVID-19 vaccine products
Japanese Society for Pharmacoepidemiology ; Japanese Epidemiological ASSOCIATION ; Society for Clinical Epidemiology ; The Japanese Society for Vaccinology
Japanese Journal of Pharmacoepidemiology 2021;26(1):1-4
5.Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2016)
Chinese Society of Clinical Oncology (CSCO) ; Chinese Society of Hematology (CSH) ; Union for China Lymphoma Investigators (UCLI)
Chinese Journal of Hematology 2016;37(6):441-452
6.Expert consensus on risk prevention and control of multiple drug use in elderly patients with cardiovascular diseases and neuropsychiatric diseases
China Pharmacy 2022;33(23):2817-2825
Multiple drug use is very common in the elderly, which will significantly increase drug interactions and adverse drug reactions. Cardiovascular disease complicated with neuropsychiatric disease is the most common multi-disease comorbidity among the elderly, and it is also one of the disease combinations involving the most multiple drug use. In order to reduce the adverse clinical outcomes of the elderly in China, Chinese Society of Clinical Pharmacy of Chinese Medical Association organized relevant experts to develop Expert Consensus on Risk Prevention and Control of Multiple Drug Use in Elderly Patients with Cardiovascular Diseases and Neuropsychiatric Diseases in China by using foreign drug use risk assessment tools and combining relevant evidence-based results, and further promote its application in clinical disease treatment practice to reduce the adverse clinical outcomes of the elderly in China.
9.Reflecting on activities over the past decade and considering future developments
Masaaki SUGAWARA ; Nobutatsu FURUSE ; Hisashi SHINBARA
Journal of the Japan Society of Acupuncture and Moxibustion 2022;72(3):174-189
The safety committee has been undertaking activities, such as conducting regular workshops at the annual congresses, managing the "Safety Measures Website for Acupuncture and Moxibustion," researching the literature, conducting multicenter prospective studies on acupuncture and moxibustion-related adverse events, collecting information about medical accidents involving acupuncture and moxibustion in Japan, addressing the media pertaining to false information regarding the safety of acupuncture and moxibustion, and formulating the Safety Guidelines for Japanese Acupuncture and Moxibustion Practice. At the 71st annual Tokyo congress workshop, activities conducted over the past decade were summarized. Regarding the studies on acupuncture and moxibustion-related adverse events, a literature review of reports concerning acupuncture- and moxibustion-associated adverse events published globally from 2004 to 2019 was introduced. Furthermore, the results of a multicenter prospective study conducted by the safety committee were also introduced. Additionally, the Safety Guidelines for Japanese Acupuncture and Moxibustion Practice were introduced, and the results of a questionnaire survey determining the degree of recognition of these guidelines were simultaneously reported. Moreover, regarding future developments, plans to create and publish a safety manual for acupuncture and moxibustion (provisional name) were reported. In the second half of the workshop, reports on the past cases of needle breakage and retained needles were introduced under the topic "precautions and preventive measures regarding needle breakage and retained needles." Furthermore, the number of needle breakage claims filed under the liability insurance of acupuncture and moxibustion practitioners was reported. These details demonstrate that despite the common use of single-use acupuncture needles, accidents involving needle breakage still exist. Lastly, measures for reducing the difficulty in needle removal and preventing needle breakage were summarized, and opinions on the same were exchanged with the participants.